Abstract:Background: Multi-omics investigation can help shed light on the complex mechanisms underlying Major Depressive Disorder (MDD). However, the integrated genetic changes in brain structure among individual patients are not yet understood. In this study, we combined DNA methylation and gene expression data to better understand the neurobiological basis of gray matter deficits in MDD.Methods: We recruited 269 patients and 416 healthy controls (HC) and collected T1-weighted images and peripheral DNA methylation microarrays. We examined differences in gray matter volume (GMV) between groups and identified GMV changes related gene expression using imaging transcriptomic analysis. We selected differentially methylated CpG positions (DMPs) and investigated the association between DMPs and GMV in patients. Then we also examined the correlation between DNA methylation and gene expression.Findings: We found significantly decreased GMV in anterior cingulate cortex (ACC), dorsolateral prefrontal cortex, inferior frontal cortex (IFG), fusiform face cortex (FFC) in MDD. The changes in GMV were associated with genes involved in neurodevelopment, neurotransmitter regulation, and metabolism. Additionally, we found that multiple DMPs in genes of these biological processes were significantly correlated with GMV changes in the IFG, ACC and FFC across individual patients. We also found a significant negative correlation between DNA methylation and gene expression in IFG. Interpretation: Our results suggest that variations in gray matter structure in MDD may be transcriptionally and epigenetically regulated. These findings indicate that epigenetic changes in blood that are associated with brain structural deficits may serve as potential predictive biomarkers for MDD patients.Funding: This study was supported by grants from National Science Fund for Distinguished Young Scholars (81725005), NSFC-Guangdong Joint Fund (U20A6005), National Natural Science Foundation of China (62176129) and China Postdoctoral Science Foundation (2022M721681).Declaration of Interest: The authors declare no competing interests.Ethical Approval: The participants over 18 year old signed a written consent form themselves. If the participants age were less than 18 years, their parental/legal guardian provided written informed consent. This study was approved by the Ethics Committee of the first affiliated Hospital of China Medical University.

Association Analysis of Gene Expression and Brain Image Identifies Gene Signatures in Major Depression Disorder

Gene expression and brain imaging association study reveals gene signatures in major depressive disorder

Microarray Analysis of the Major Depressive Disorder Mrna Profile Data.

A Joint Study of Whole Exome Sequencing and Structural MRI Analysis in Major Depressive Disorder.

Gene Expression Analysis of Multiple Brain Regions in Major Depressive Disorder

Integrative omics analysis reveals epigenomic and transcriptomic signatures underlying brain structural deficits in major depressive disorder

Molecular, Functional, and Structural Imaging of Major Depressive Disorder

Connectome Analysis of Functional and Structural Hemispheric Brain Networks in Major Depressive Disorder

Transcriptional and Cellular Signatures of Morphometric Similarity Remodeling in Major Depressive Disorder

Cortical Structural Differences in Major Depressive Disorder Correlate with Cell Type-Specific Transcriptional Signatures

Altered intersubject functional variability of brain white‐matter in major depressive disorder and its association with gene expression profiles

Local dynamic spontaneous brain activity changes in first-episode, treatment-naïve patients with major depressive disorder and their associated gene expression profiles

Transcriptomic decoding of regional cortical vulnerability to major depressive disorder

Multi-Omics Integration Reveals Transcriptomic and Epigenetic Signatures Underlying Brain Structural Deficits in Major Depressive Disorder

Identification of Major Depressive Disorder Disease-Related Genes and Functional Pathways Based on System Dynamic Changes of Network Connectivity.

Brain connectivity and transcriptomic similarity inform abnormal morphometric similarity patterns in first-episode, treatment-naïve major depressive disorder

Elucidating genetic and molecular basis of altered higher-order brain structure-function coupling in major depressive disorder

Analysis of Differentially Expressed Genes in the Dentate Gyrus and Anterior Cingulate Cortex in a Mouse Model of Depression

Essential brain structural alterations in major depressive disorder: A voxel-wise meta-analysis on first episode, medication-naive patients.

Brain structure alterations in depression: Psychoradiological evidence

Gene Expression Signatures Differentiating Major Depressive Disorder from Subsyndromal Symptomatic Depression.